It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
originally posted by: carewemust
originally posted by: Nothin
a reply to: carewemust
The precedent was set but 2 months ago, and now we see what their vision of the ' New Normal™ ' entails.
Medical experimentation on the public at large.
With no liability for the consequences.
And mega billions in profit !!
What a business model !!
Our leaders are psychopaths, and we just let them push it further and further.
Most things eventually snap, when pushed too far.
Joe Biden says he's forcing Pfizer and Moderna to churn out 600 million doses before July 1st.
What happens if come July 1st, a Covid-19 variant is most dangerous...a variant that the 600 million doses wasn't designed to treat?
originally posted by: carewemust
Tuesday, February 23, 2021
Second Concern: If 35 million people have been vaccinated against the original Covid-19, then the vaccine is "tweaked" to make it also more effective against a fast-spreading Covid-19 variant, those 35 million are suddenly not inoculated against that variant. What are they to do?
-CareWeMust
originally posted by: carewemust
Tuesday, February 23, 2021
When you consider that neither Pfizer or Moderna Covid-19 vaccines are fully approved by the Food and Drug Administration, it's somewhat mind-boggling that the FDA would authorize Pfizer/Moderna to "tweak" their vaccine formulas as they see fit, with no additional trials/testing required.
Extracted from: news.yahoo.com...
Monday, February 22, 2021
The U.S. Food and Drug Administration issued new guidance Monday that streamlines the vetting process for COVID-19 vaccines that are modified to target new coronavirus variants.
The recommendations, detailed in a 24-page document on the FDA’s website, are intended to speed up the review process amid worries that the new variants — some more contagious, some more able to evade current vaccines — will undermine efforts to halt the virus’ spread.
“We know the country is eager to return to a new normal and the emergence of the virus variants raises new concerns about the performance of these products,” Dr. Janet Woodcock, the FDA's acting commissioner, said in a statement.
“By issuing these guidances, we want the American public to know that we are using every tool in our toolbox to fight this pandemic, including pivoting as the virus adapts.”
The recent emergence of a spate of variants has led to rising concerns that the first generation of vaccines — which were developed based on an early version of the coronavirus — may not be well-equipped to protect people against the mix of viruses currently in circulation.
Here is the referenced FDA Guidance document: www.fda.gov...
First Concern: If a medication approved for "Emergency Use Only" by the Food and Drug Administration, the manufacturer should not be allowed to further experiment with the medication/vaccine, by tweaking the formula.
Second Concern: If 35 million people have been vaccinated against the original Covid-19, then the vaccine is "tweaked" to make it also more effective against a fast-spreading Covid-19 variant, those 35 million are suddenly not inoculated against that variant. What are they to do?
Are there additional concerns? Do the potential benefits from this flexibility outweigh the risks, in your opinion?
-CareWeMust